In this study, western blot (WB) analysis from ten endometrial cancer vs six normal endometrium was used to validate the abundance of the four proteins which discriminate unambiguously between cases and controls (ABRACL, PGAM2, FGB, ANXA3). This evidence concerns the gene ABRACL and endometrial cancer.